drugset / Trial / NCT01948765

Xenon as an Adjuvant to Propofol Anaesthesia in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery.

NCT01948765

Phase 2 Completed 50 enrolled Universitaire Ziekenhuizen KU Leuven
RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators hypothesize that the application of 30% xenon as an adjuvant to general anesthesia with a target-controlled infusion of propofol is superior to general anesthesia with propofol alone with respect to hemodynamic stability.

Timeline

Start
2013-06
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule
Comparator Xenon Other / unclassified 30 %